Literature DB >> 8699933

Effect of growth hormone, insulin and dexamethasone on 11 beta-hydroxysteroid dehydrogenase activity on a primary culture of rat hepatocytes.

Y J Liu1, Y Nakagawa, K Nasuda, H Saegusa, Y Igarashi.   

Abstract

11 beta-hydroxysteroid dehydrogenase (11 beta-HSD) is a microsomal enzyme present in the peripheral tissues of the rat, including the liver, and is mediated by a number of factors in animal in vivo studies. However, the effect of peptide hormones and glucocorticoids on the activity of 11 beta-HSD in isolated rat hepatocytes is not clear. To investigate these effects, we determined 11 beta-HSD activity in a primary culture of rat hepatocytes by adding various concentrations of growth hormone, insulin and dexamethasone (Dex). 11 beta-HSD activity increased significantly after treatment with Dex (10(-9)M-10(-6)M) for 48h. Dex (100nM) treated hepatocytes, incubated for 12h to 48h, resulted in a significant two-to four-fold rise in 11 beta-HSD activity compared to control (p < 0.01), which was in contrast to GH (10(-9)M-10(-6)M) and insulin (10(-8)M-10(-5)M), which inhibited 11 beta-HSD activity (p < 0.05). These results suggest that the 11 beta-HSD of rat hepatocytes is under multifactorial regulation; Dex stimulates and GH and insulin inhibit 11 beta-HSD activity in primary cultures of rat hepatocytes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8699933     DOI: 10.1016/0024-3205(96)00288-3

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  8 in total

Review 1.  Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 in obesity.

Authors:  Deborah J Wake; Brian R Walker
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

2.  Insulin and dexamethasone dynamically regulate adipocyte 11beta-hydroxysteroid dehydrogenase type 1.

Authors:  Aran Balachandran; Haiyan Guan; Michael Sellan; Stan van Uum; Kaiping Yang
Journal:  Endocrinology       Date:  2008-05-08       Impact factor: 4.736

Review 3.  Tissue-specific dysregulation of cortisol regeneration by 11βHSD1 in obesity: has it promised too much?

Authors:  Andreas Stomby; Ruth Andrew; Brian R Walker; Tommy Olsson
Journal:  Diabetologia       Date:  2014-04-08       Impact factor: 10.122

Review 4.  11β-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action.

Authors:  Karen Chapman; Megan Holmes; Jonathan Seckl
Journal:  Physiol Rev       Date:  2013-07       Impact factor: 37.312

5.  Central glucocorticoid administration promotes weight gain and increased 11β-hydroxysteroid dehydrogenase type 1 expression in white adipose tissue.

Authors:  Christelle Veyrat-Durebex; Nicolas Deblon; Aurélie Caillon; Ruth Andrew; Jordi Altirriba; Alex Odermatt; Françoise Rohner-Jeanrenaud
Journal:  PLoS One       Date:  2012-03-30       Impact factor: 3.240

6.  Diabetes and Insulin Injection Modalities: Effects on Hepatic and Hippocampal Expression of 11β-Hydroxysteroid Dehydrogenase Type 1 in Juvenile Diabetic Male Rats.

Authors:  Véronica Rougeon; Marie-Pierre Moisan; Nicole Barthe; Marie-Christine Beauvieux; Jean-Christophe Helbling; Véronique Pallet; Nathalie Marissal-Arvy; Pascal Barat
Journal:  Front Endocrinol (Lausanne)       Date:  2017-04-18       Impact factor: 5.555

7.  Steroid metabolomic signature of liver disease in nonsyndromic childhood obesity.

Authors:  Aneta Gawlik; Michael Shmoish; Michaela F Hartmann; Stefan A Wudy; Zbigniew Olczak; Katarzyna Gruszczynska; Ze'ev Hochberg
Journal:  Endocr Connect       Date:  2019-06       Impact factor: 3.335

Review 8.  Modulation of 11β-hydroxysteroid dehydrogenase as a strategy to reduce vascular inflammation.

Authors:  Patrick W F Hadoke; Tiina Kipari; Jonathan R Seckl; Karen E Chapman
Journal:  Curr Atheroscler Rep       Date:  2013-05       Impact factor: 5.113

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.